Skip to main content

Advertisement

Log in

Erbium:YAG laser treatment of female stress urinary incontinence: midterm data

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Stress urinary incontinence (SUI) is treated using intravaginal laser therapy. We wanted to find out how incontinence severity at baseline and the number of laser interventions affect success rate, and whether the effect of laser therapy was obvious 6 months and 2 years after the last laser intervention.

Methods

Fifty-nine women, 32 with SUI I, 16 with SUI II, and 11 with SUI III were treated using an erbium-doped yttrium aluminium garnet (Er:YAG) laser following the IncontiLase® protocol. Therapy included five laser sessions with a 1-month interval between sessions. Objective (1-h pad test) and subjective data (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form [ICIQ-UI SF], Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire [PISQ-12]) were assessed at baseline, after two and four laser sessions and 6 months and 2 years after the fifth laser session.

Results

Objective cure/improve rates for mild SUI I were 69%, 78%, 91%, and 78% after two, four, and five laser sessions at the 6-month and 2-year follow-ups. Subjective cure rates (ICIQ-UI SF) were 53%, 69%, 72%, and 66%, and sexual function (PISQ-12) also improved. For SUI II, objective cure/improve rates were 31%, 63%, 69%, and 50%. Subjective cure rate was 13% at the 2-year follow-up. For SUI III, only one patient had an objective improvement after two and four laser sessions.

Conclusions

Intravaginal laser therapy led to cure/improvement for SUI I and SUI II, but not for severe SUI III. Outcome was better after four to five laser sessions than after two laser sessions. Follow-up data 6 months and 2 years after laser intervention showed sustainability of the treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. DeLancey JO, Trowbridge ER, Miller JM, Morgan DM, Guire K, Fenner DE, et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol. 2008;179:2286–90 discussion 90.

    Article  Google Scholar 

  2. Fistonić I, Findri Guštek S, Fistonić N. Minimally invasive laser procedure for early stages of stress urinary incontinence (SUI). J Laser Health Academy. 2012;1:67–74.

    Google Scholar 

  3. Reisenauer C, Muche-Borowski C, Anthuber C, Finas D, Fink T, Gabriel B, et al. Interdisciplinary S2e guideline for the diagnosis and treatment of stress urinary incontinence in women: short version—AWMF registry no. 015-005, July 2013. Geburtshilfe Frauenheilkd. 2013;73:899–903.

    Article  CAS  Google Scholar 

  4. Elmelund M, Sokol ER, Karram MM, Dmochowski R, Klarskov N. Patient characteristics that may influence the effect of urethral injection therapy for female stress urinary incontinence. J Urol. 2019;202:125–31.

    Article  Google Scholar 

  5. Zivanovic I, Rautenberg O, Lobodasch K, von Bunau G, Walser C, Viereck V. Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure. Neurourol Urodyn. 2017;36:722–6.

    Article  CAS  Google Scholar 

  6. Gonzalez Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018;29:211–5.

    Article  Google Scholar 

  7. Mothes AR, Runnebaum M, Runnebaum IB. An innovative dual-phase protocol for pulsed ablative vaginal erbium:YAG laser treatment of urogynecological symptoms. Eur J Obstet Gynecol Reprod Biol. 2018;229:167–71.

    Article  Google Scholar 

  8. Fistonić N, Fistonić I, Gustek SF, Turina IS, Marton I, Vizintin Z, et al. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women—a pilot study. Lasers Med Sci. 2016;31:635–43.

    Article  Google Scholar 

  9. Lukac M, Gaspar A, Bajd F. Dual tissue regeneration: non-ablative resurfacing of soft tissues with FotonaSmooth® mode Er:YAG laser. J Laser Health Academy. 2018;1:1–15.

    Google Scholar 

  10. Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med. 2017;162:510–4.

    Article  CAS  Google Scholar 

  11. Gambacciani M, Torelli MG, Martella L, Bracco GL, Casagrande AG, Albertin E, et al. Rationale and design for the vaginal erbium laser academy study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18(Suppl 1):43–8.

    Article  Google Scholar 

  12. Ogrinc UB, Sencar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015;47:689–97.

    Article  Google Scholar 

  13. Tien YW, Hsiao SM, Lee CN, Lin HH. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J. 2017;28:469–76.

    Article  Google Scholar 

  14. Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 2019;37:885–9.

    Article  Google Scholar 

  15. Blaganje M, Scepanovic D, Zgur L, Verdenik I, Pajk F, Lukanovic A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018;224:153–8.

    Article  Google Scholar 

  16. Drnovsek-Olup B, Beltram M, Pizem J. Repetitive Er:YAG laser irradiation of human skin: a histological evaluation. Lasers Surg Med. 2004;35:146–51.

    Article  Google Scholar 

  17. Pergialiotis V, Prodromidou A, Perrea DN, Doumouchtsis SK. A systematic review on vaginal laser therapy for treating stress urinary incontinence: do we have enough evidence? Int Urogynecol J. 2017;28:1445–51.

    Article  Google Scholar 

  18. Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T, Research I, Development C. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J. 2019;30:371–6.

    Article  Google Scholar 

  19. Bhide AA, Khullar V, Swift S, Digesu GA. The use of laser in urogynaecology. Int Urogynecol J. 2019;30:683–92.

    Article  Google Scholar 

  20. Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–5.

    Article  Google Scholar 

  21. Kociszewski J, Rautenberg O, Kuszka A, Eberhard J, Hilgers R, Viereck V. Can we place tension-free vaginal tape where it should be? The one-third rule. Ultrasound Obstet Gynecol. 2012;39:210–4.

    Article  CAS  Google Scholar 

  22. Krhut J, Zachoval R, Smith PP, Rosier PF, Valansky L, Martan A, et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2014;33:507–10.

    Article  Google Scholar 

  23. Wlazlak E, Viereck V, Kociszewski J, Kuszka A, Rautenberg O, Walser C, et al. Role of intrinsic sphincter deficiency with and without urethral hypomobility on the outcome of tape insertion. Neurourol Urodyn. 2017;36:1910–6.

    Article  CAS  Google Scholar 

  24. Ghoniem G, Stanford E, Kenton K, Achtari C, Goldberg R, Mascarenhas T, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:5–33.

    Article  CAS  Google Scholar 

  25. Vizintin Z, Rivera M, Fistonić I, Saraçoğlu F, Guimares P, Gaviria J, et al. Novel minimally invasive VSP Er:YAG laser treatments in gynecology. J Laser Health Academy. 2012;1:46–58.

    Google Scholar 

  26. Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009;28:411–5.

    Article  Google Scholar 

  27. Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J. 2003;14:164–8 discussion 8.

    Article  Google Scholar 

  28. Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J. 2004;15:219.

    Article  Google Scholar 

  29. Escribano JJ, Gonzalez-Isaza P, Tserotas K, Athanasiou S, Zerbinati N, Leibaschoff G, et al. In response to the FDA warning about the use of photomedicine in gynecology. Lasers Med Sci. 2019;34:1509–11.

    Article  Google Scholar 

  30. Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21:148–52.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Volker Viereck.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuszka, A., Gamper, M., Walser, C. et al. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data. Int Urogynecol J 31, 1859–1866 (2020). https://doi.org/10.1007/s00192-019-04148-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-019-04148-9

Keywords

Navigation